← Open Payments lookup

AMIRREZA FALLAHI: Open Payments

NPI 1235766916 · BRADLEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$349 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $349

Food & beverage: $349
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$103
Otsuka America Pharmaceutical, Inc.3$78
Teva Pharmaceuticals USA, Inc.2$44
ABBVIE INC.1$28
Luye Pharma (USA) Ltd.1$25
Neurocrine BioSciences, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Lundbeck LLC1$17
Biogen, Inc.1$15

Products named: COBENFY, ABILIFY MAINTENA, AUSTEDO XR, ABILIFY ASIMTUFII, VRAYLAR, ERZOFRI EXTENDED-RELEASE, INGREZZA, REXULTI.

Industry payments across IL — which companies pay providers there.